This conference grew out of a discussion among a few psychologists who noticed a growing number of their clients were using cannabis for medical reasons. We were not sure how to respond. We didn’t know what the science had to say – nor did we know what the practice actually was. We did know that people have strong opinions about it.
We discovered that the number of New Hampshire residents using medical cannabis has nearly quadrupled since the Therapeutic Cannabis program began in 2016. As a growing number of their clients receive medical cannabis cards Mental Health Practitioners are discovering their need for training in this area. There are serious challenges APA and scientists, in general, are having with getting permission to research Medical Cannabis, which is classified as a Schedule 1 drug, for example in a recent press release APA called upon the US Attorney General to grant permission to scientists who have applied to do research on cannabis. Those who have studied the Science of Medical Cannabis realize more research and training is needed to help psychologists and mental health care providers understand how medical cannabis works and what the current science shows in terms of what conditions can be effectively treated with Cannabis.
We have assembled four clinicians from New England to explain to us the current state of the science and practice regarding medical cannabis
Dr. Dustin Sulak, D.O., Diplomat of the American Academy of Cannabinoid Medicine from Portland ME who lectures widely on the use of Medical Cannabis
David Syrak, M.D., the medical director of Sanctuary ATC, the medical cannabis dispensary in Plymouth, NH.
Lisa C. Withrow, APRN, NP-C, ACHPN co-founder of the Palliativity Medical Group in Bedford, NH who has extensive experience determining if her patients should be certified to use Medical Cannabis
Vicki Anderson, Psy.D. Private Practice in Newbury NH and graduate of the University of Vermont Professional Certificate in Cannabis Science and Medicine
At the conclusion of this program, participants will be able to:
Explain the basic structure and function of the endocannabinoid system.
Describe the therapeutic potential of various cannabinoids
Identify medical risks and side effects associated with cannabis use.
Describe at least four different methods of cannabis administration.
Describe the concept of endocannabinoid deficiency syndrome
Identify the process of obtaining a medical card in the state of NH and the medical conditions approved by the NH Therapeutic Cannabis program.
This program is co-sponsored by the New Hampshire Psychological Association (NHPA) and The Positivity Company. NHPA is approved by the American Psychological Association to sponsor continuing education for psychologists. NHPA maintains responsibility for this program and its content.